ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
DelMar Pharmaceuticals Inc

DelMar Pharmaceuticals Inc (DMPI)

1.34
0.00
(0.00%)
Cerrado 23 Noviembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.34
Postura de Compra
1.32
Postura de Venta
1.34
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
1.34
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
55,305,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-49.06
Beneficio por acción (BPA)
-0.15
turnover
-
Beneficio neto
-8.5M

Acerca de DelMar Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Reno, Nevada, USA
Fundado
-

DMPI Últimas noticias

DelMar Announces $19.6 Million Private Placement Priced At-The-Market

DelMar Announces $19.6 Million Private Placement Priced At-The-Market PR Newswire SAN DIEGO, Aug. 18, 2020 SAN DIEGO, Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI...

DelMar Announces Approval of Merger by Stockholders

DelMar Announces Approval of Merger by Stockholders PR Newswire SAN DIEGO, Aug. 17, 2020 SAN DIEGO, Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the...

DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals

DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET PR Newswire SAN DIEGO...

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Resear...

DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083's Participation in a Pivotal Study for...

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed an...

DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II Findings Support...

DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline

DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline Combination creates a diversified biopharmaceutical company with a robust product pipeline targeting rare, unmet...

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal...

Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals' VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Canc...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II PR Newswire SAN DIEGO, June 1...

DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates

DelMar Pharmaceuticals Announces Fiscal Third Quarter 2020 Financial Results and Recent Corporate Updates PR Newswire SAN DIEGO, May 13, 2020 SAN DIEGO, May 13, 2020 /PRNewswire/ -- DelMar...

DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment o...

DelMar Pharmaceuticals [Nasdaq:DMPI] Provides Enrollment Update in Phase 2 Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors Phase 2 trial more than 90% enrolled with enrollment...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
107.91M
Truth_is_a_tool Truth_is_a_tool 36 segundos hace
””Going to be a lot of angry people next week””

Who ? You and your multiple personalities ?! 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
KBLB
NASDAQ2020 NASDAQ2020 38 segundos hace
Elite needs to continue on with DRUG C NDA
abuse deterrent opioid that contains no naltrexone
making it 90% cheaper than expensive SeQuestox
ELTP
ramfan60 ramfan60 1 minuto hace
Nice.....I like him. He gets it.
AMRN
#1 PATRIOTS_RSOX FAN #1 PATRIOTS_RSOX FAN 2 minutos hace
Where is Dilution King Edward. 

Come out come out wherever you are. POS 
SUTI
WebSlinger WebSlinger 2 minutos hace
Here is a comment yesterday from the KBLB FB group:

"I sold my 500,000 shares this week. Lost a few 1000 in the process. Tired of waiting. 7yrs!"
KBLB
Smartypants2 Smartypants2 3 minutos hace
XERIANT SRO (Europe) was a separate company started by Henry Biza that was supposed to bring foreign technologies (like Movychem's) to the attention of Xeriant (US). As best as I can determine, at some point Movychem decided to work directly with Xeriant (US). (Remember how Duffy had to fly to Easte
XERI
fza fza 3 minutos hace
Yeah, I think we all missed it. He must of mistakenly sent it to all his Buttbook friends. LOL
KBLB
barrydingle barrydingle 5 minutos hace
Nervous system overload

Information induced
MEDH
urge2surge urge2surge 5 minutos hace
You didn't see it because you weren't on the webinar. That was my take. Your now on my Iggy list.
Spin away all you want.
GMER
adesell adesell 6 minutos hace
So now we know the "acquisition" was just a pump attempt. Failed even at that. LOL Revenues are down 90% year to year. Ticker symbol and cusip change is "75% completed" after over 2 years. Like I said...this is DONE. Trips by the end of the year. Mark it. Last ones with the million shares turn the l
GDVM
WebSlinger WebSlinger 6 minutos hace
>

LOL
KBLB
Biowatch Biowatch 7 minutos hace
FDA finds that asthma drug Singulair affects brain
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-finds-widely-used-asthma-drug-impacts-brain-2024-11-22/
-Singulair binds to brain receptors affecting psychiatric functions
-Merck spinoff Organon confident in S
MRK
weedtrader420 weedtrader420 7 minutos hace
Anyone calling for BITCOIN to dump is just jealous they don’t have no BITCOIN
BTCUSD
silkcash silkcash 8 minutos hace
Oh, I’m sorry I missed it. Can you repeat what Ben told you?
KBLB
Gmenfan Gmenfan 9 minutos hace
I'm e-mailing that one out. Thanks!!!!
NASDAQ2020 NASDAQ2020 10 minutos hace
That will reduce quotas for non-ADF IR Oxycodone.

ELTP
ELTP
glenn1919 glenn1919 10 minutos hace
GRPO...................................https://stockcharts.com/h-sc/ui?s=GPRO&p=W&b=5&g=0&id=p86431144783
GPRO
weedtrader420 weedtrader420 10 minutos hace
☕️🫖🫲😁👍 he doesn’t have a clue he doesn’t even have a cell phone. he has to go to the library to use computer.🤣😂🤣 amusements only $120k target thanksgiving
BTCUSD
barrydingle barrydingle 10 minutos hace
And the panicy insiders

This guy warns about "having numbers" and to watch out?
We have the numbers and a whole lot more.
Have you noticed that the mention of BLLB control person LILY RHODEHAMEL sets them off?
BLLB
BurgerKing82 BurgerKing82 11 minutos hace
Steady volume here
BEGI
glenn1919 glenn1919 11 minutos hace
COMM............................https://stockcharts.com/h-sc/ui?s=COMM&p=W&b=5&g=0&id=p86431144783
COMM
Canna_Business Canna_Business 11 minutos hace
Pathway to Medical Cannabis: Saving Lives Through Policy and Innovation

1. DEA Action: Removing cannabis from Schedule 1 enables life-saving research, unlocking safer alternatives to opioids.

2. FDA Research: Clinical trials confirm cannabis is effective for chronic pai
Canna_Business Canna_Business 11 minutos hace
Pathway to Medical Cannabis: Saving Lives Through Policy and Innovation

1. DEA Action: Removing cannabis from Schedule 1 enables life-saving research, unlocking safer alternatives to opioids.

2. FDA Research: Clinical trials confirm cannabis is effective for chronic pai
glenn1919 glenn1919 12 minutos hace
PLBY........https://stockcharts.com/h-sc/ui?s=PLBY&p=W&b=5&g=0&id=p86431144783
PLBY

Su Consulta Reciente

Delayed Upgrade Clock